<DOC>
	<DOCNO>NCT03019848</DOCNO>
	<brief_summary>The purpose study determine oral supplementation curcumin reduces proteinuria , improve redox pro-inflammatory state patient chronic kidney disease associate Diabetes mellitus .</brief_summary>
	<brief_title>Effect Oral Supplementation With Curcumin Patients With Proteinuric Diabetic Kidney Disease</brief_title>
	<detailed_description>Diabetic Kidney Disease ( DKD ) represent fist cause end-stage kidney disease Mexico world , characterize presence hyperfiltration , glomerular hypertrophy , tubular albuminuria mesangial matrix expansion , mainly oxidative stress pro-inflammatory state . Current treatment limit control proteinuria delay progression disease , even optimal management , significant number patient progress end-stage renal disease . Curcumin , find extract rhizome plant Curcuma longa L. , wide spectrum biological pharmacological activity , anti-oxidant , anti-inflammatory , anti-carcinogenic anti-diabetic effect . It capacity act directly highly reactive oxygen specie , induce expression various cytoprotective protein Keap1/Nrf2/ARE pathway reduce inflammatory transcription factor NF-κB TNF-α . Curcumin could adjuvant treatment management DKC due pleiotropic nature , low cost side effect .</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Diagnosis Diabetes Mellitus type 2 proteinuric kidney disease 1000 mg protein daily recollection Glomerular filtration rate 1560 mL/min/ 1.73 m2 calculate CKDEPI Patients take Angiotensin II Receptor Blocker ACE inhibitor Renal replacement therapy Autoimmune disease malignancy Pregnancy Hepatic damage Congestive heart failure classification III IV ( NYHA ) History organ transplantation History chemotherapy immunosuppression within 2 year prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Redox pro-inflammatory status</keyword>
</DOC>